Concord Wealth Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5	Closed	-$201	–	976
2024 Q4	$201	Hold	5	–	–	﹤0.01%	891
2024 Q3	$317	Buy	+5	New	+$317	﹤0.01%	916